Hims & Hers Health Inc. ($HIMS) Stock Forecast: Down 6.1% Today

What is Hims & Hers Health Inc.?

Hims & Hers Health, Inc. (HIMS) closed at $26.90 today, showing a slight positive movement from the previous trading session.

Why is Hims & Hers Health Inc. going down?

HIMS stock is down 6.1% on Jan 8, 2025 19:37

• The bearish movement observed today in HIMS stock could be due to profit-taking by investors following a recent uptrend.
• The slight positive movement in the prior trading session could have falsely reassured investors, leading to a sell-off today.
• Market sentiment towards the health and wellness sector potentially changed, affecting HIMS stock negatively.
• The bearish movement in HIMS may also be influenced by broader market trends or economic indicators impacting the sector.

HIMS Price Chart

HIMS Technical Analysis

HIMS News

Hims & Hers Health, Inc. ( HIMS ) Laps the Stock Market: Here's Why

Hims & Hers Health, Inc. (HIMS) closed the most recent trading day at $26.90, moving +1.01% from the previous trading session.

https://www.zacks.com/stock/news/2392469/hims-hers-health-inc-hims-laps-the-stock-market-heres-why

Trending Today

Pepe ($PEPE) Crypto Forecast: Down 8.1% Today

Shiba Inu ($SHIB) Crypto Forecast: Down 5.9% Today

Cardano ($ADA) Crypto Forecast: Down 6.8% Today

Macy's Inc ($M) Stock Forecast: Down 5.4% Today

Ethereum ($ETH) Crypto Forecast: Down 7.0% Today

Cassava Sciences, Inc. ($SAVA) Stock Forecast: Down 5.2% Today

Aave ($AAVE) Crypto Forecast: Down 8.0% Today

Five Below Inc. ($FIVE) Stock Forecast: Down 5.4% Today

Polkadot ($DOT) Crypto Forecast: Down 7.3% Today

Bonk ($BONK) Crypto Forecast: Down 10.5% Today

Hims & Hers Health Inc. Price History

18.10.2024 - HIMS Stock was up 5.4%

• The bullish movement in HIMS stock could be attributed to the company's efforts to enhance its offerings and expand its health and wellness products and services.
• The positive sentiment towards HIMS could also be influenced by the bullish stance taken by investors with significant capital.
• The stock might have also benefited from the overall market optimism or specific sector trends, despite potential macro challenges that could impact its performance.
• The dip in HIMS stock price due to Amazon's new pricing strategy for telehealth services might have been overshadowed by the positive developments and investor sentiment, leading to the overall bullish movement.

18.10.2024 - HIMS Stock was up 7.2%

• The bullish movement in HIMS stock could be linked to the interest of deep-pocketed investors in the company, as shown by significant options trading trends favoring Hims & Hers Health.
• Though there was a recent decrease in stock price over the past month, the notable increase in the stock price over the past year may have boosted investor confidence, leading to today's spike.
• The negative reaction to a competitor's new upfront pricing for telehealth services may have initially caused a dip in HIMS stock. However, the subsequent recovery and bullish movement suggest that investors are more focused on the company's growth potential and product expansions.
• HIMS' initiatives to improve its offerings and expand its health and wellness product range might have positively impacted investor sentiment, overshadowing potential macro challenges that could affect its future performance.

02.11.2024 - HIMS Stock was down 5.0%

• Despite increased options activity pointing towards optimism among investors, Hims & Hers Health (HIMS) faced significant downward movement today.
• Speculation around Marty Makary's potential nomination by President-elect Donald Trump as FDA head initially influenced stock performance, but various market conditions or internal factors likely drove the bearish trajectory.
• Unspecified internal factors within the company may have contributed to investor negativity, overshadowing positive news regarding FDA leadership appointments.
• Traders should monitor forthcoming updates from Hims & Hers Health to gain insight into the reasons behind the current bearish market movement.

26.10.2024 - HIMS Stock was up 6.2%

• Hims & Hers Health stock saw a significant increase following the nomination of Marty Makary by President-elect Donald Trump to lead the FDA, suggesting possible positive regulatory changes in healthcare.
• The market reacted favorably to this news, as a new FDA leader could bring reforms that benefit companies like Hims & Hers Health in the healthcare industry.
• Investors view this development as a notable opportunity for Hims & Hers Health to enhance its telehealth services and product offerings in a potentially favorable regulatory environment.

18.11.2024 - HIMS Stock was down 5.1%

• Despite recent positive news about robust revenue growth and subscriber numbers, HIMS stock experienced a bearish trend today.
• The bullish stance taken by whales and investors in the options market did not translate into a positive movement in the stock price.
• It is possible that profit-taking or market sentiment shifts led to the bearish movement, despite the optimistic outlook for the company's future growth.
• Investors may be cautious about the sustainability of Hims & Hers Health's growth trajectory, leading to the sell-off seen in the stock today.

27.11.2024 - HIMS Stock was down 5.5%

• There has been a notable increase in bearish options activity on Hims & Hers Health, hinting at a lack of confidence among financial giants, with a majority of traders exhibiting bearish tendencies.
• The prevalence of bearish trades and minimal positive sentiment could signify investor apprehensions regarding the company's future performance and growth prospects.
• The downward trend in HIMS stock may be linked to potential adverse developments, a bleak earnings outlook, or general uncertainties affecting the telehealth industry, resulting in a significant sell-off.
• Investors appear to be responding to specific worries about Hims & Hers Health's business model, competitive standing, or regulatory hurdles, leading them to adopt a more pessimistic view of the stock.

31.11.2024 - HIMS Stock was down 5.3%

• The Chief Operating Officer, Melissa Baird, exercised stock options valued at $658K, potentially indicating insider sentiment or profit-taking, which might have influenced the bearish movement.
• Bearish options activity notably increased, with a small 11% of traders displaying bullish tendencies and a larger 66% showing bearish sentiments. This surge in negativity could have added selling pressure, contributing to the stock's decline.
• The combination of insider selling and prevailing bearish sentiment in options trading could have influenced investors negatively, thus leading to the significant bearish movement witnessed in Hims & Hers Health stock recently.

12.11.2024 - HIMS Stock was up 9.8%

• Unusual options activity on HIMS suggests a bullish stance by investors with significant capital.
• The increased interest in call options could indicate a positive sentiment and potential upside in the stock.
• This bullish movement could be driven by expectations of strong financial performance or potential positive developments within the company, leading to increased investor confidence and buying pressure.

08.00.2025 - HIMS Stock was down 6.1%

• The bearish movement observed today in HIMS stock could be due to profit-taking by investors following a recent uptrend.
• The slight positive movement in the prior trading session could have falsely reassured investors, leading to a sell-off today.
• Market sentiment towards the health and wellness sector potentially changed, affecting HIMS stock negatively.
• The bearish movement in HIMS may also be influenced by broader market trends or economic indicators impacting the sector.

04.11.2024 - HIMS Stock was up 5.4%

• The stock of HIMS experienced a strong bullish movement today.
• Despite the bearish moves made by financial giants, the surge in bullish options activity by deep-pocketed investors indicates a positive sentiment towards Hims & Hers Health.
• The conflicting actions of traders, with 20% being bullish and 70% showing bearish tendencies, might have created some volatility in the market.
• Overall, the bullish approach adopted by significant investors could have outweighed the bearish sentiment, leading to the strong upward movement in HIMS stock.

16.11.2024 - HIMS Stock was up 5.5%

• The stock showed significant upward momentum today.
• Q3 revenues were reported at $401.6 million, marking a 77% growth compared to the previous year, with a subscriber base exceeding 2 million.
• Investors are expressing optimism towards HIMS, evident in the unusual options activity.
• The company's optimistic forecast for 2024, aiming to surpass $1.5 billion in revenues, is likely boosting investor confidence and driving the stock's upward trend.

19.11.2024 - HIMS Stock was down 17.0%

• The stock of Hims & Hers Health saw significant downward movement today.
• This decline could be linked to the U.S. Food and Drug Administration's statement about tirzepatide injection shortages affecting the company's pharmaceutical line.
• Despite the recent decrease, the company has demonstrated promising growth potential with substantial revenues and subscriber numbers, suggesting a favorable outlook ahead if they can tackle supply chain issues effectively.